Jefferies Downgrades Allscripts-Misys Healthcare (MDRX) to Hold

Jefferies downgraded Allscripts-Misys Healthcare (NASDAQ: MDRX) from Buy to Hold with a price target of $10.50 (down from $25).

The firm comments, "Poor operating results, weak bookings, a Board room power struggle, and reporting changes (to add confusion) are enough to downgrade. Delays around ADX 1.5 diminishes MDRX's ability to put up a fight against Epic and Cerner's (CERN, $73.82, NC) inpatient share gains. The value we saw in MDRX's ambulatory base also could deteriorate, as a preoccupied management team tries to steady the rudder."

Q2 EPS goes from $0.26 to $0.20, FY12 from $1.07 to $0.76 and FY13 from $1.24 to $0.90.


For an analyst ratings summary and ratings history on Allscripts-Misys Healthcare click here. For more ratings news on Allscripts-Misys Healthcare click here.

Shares of Allscripts-Misys Healthcare closed at $16.02 yesterday.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Citi Upgrades Sirius XM Radio (SIRI) to Neutral, 'risk-reward is balanced at prevailing levels'
• Ameriprise Financial (AMP) PT Raised to $445 at Morgan Stanley
• Citi Upgrades United Microelectronics Corp (2303:TT) (UMC) to Buy 'with limited downside'